Review article: Chemical tools to probe cellular O-GlcNAc signalling

Biochemical Journal

Volumn 456, Issue 1, 2013, Pages 1-12

  Ostrowski, Adam ^a   Van Aalten, Daan M F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Inhibitor; O GlcNAc transferase; O GlcNAcase; O GlcNAcylation; Post translational modification

Indexed keywords

(2 ACETAMIDO 2 DEOXY 5 THIO D GLUCOPYRANOSE); (BENZYL 2 ACETAMIDO 2 DEOXY ALPHA D GALACTOPYRANOSIDE); 3 (2 ADAMANTANYLETHYL) 2 [(4 CHLOROPHENYL)AZAMETHYLENE] 4 OXO 1,3 THIAZAPERHYDROINE 6 CARBOXYLIC ACID; 4 METHOXYPHENYL 6 ACETYL 2 OXOBENZO[D]OXAZOLE 3(2H) CARBOXYLATE; 6 DIAZO 5 OXONORLEUCINE; ALLOXAN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE ENZYME; N ACETYLGLUCOSAMINESTATIN C; N ACETYLGLUCOSAMINESTATIN G; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; ST 045849; ST 060266; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL LINE; DRUG STRUCTURE; ENZYME MECHANISM; ENZYME STRUCTURE; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84886496245     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ201301081     Document Type: Review

References (116)

1. Torres, C.-R. and Hart, G. W. (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317 (Pubitemid 14130544)
2. Chou, T.-Y., Hart, G. W. and Dang, C. V. (1995) c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270, 18961-18965
3. Holt, G. D. and Hart, G. W. (1986) The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J. Biol. Chem. 261, 8049-8057 (Pubitemid 17208742)
4. Holt, G. D., Snow, C. M., Senior, A., Haltiwanger, R. S., Gerace, L. and Hart, G. W. (1987) Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell Biol. 104, 1157-64 (Pubitemid 17084473)
5. Hart, G. W., Slawson, C., Ramirez-Correa, G. and Lagerlof, O. (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80, 825-858
6. Hahne, H., Sobotzki, N., Nyberg, T., Helm, D., Borodkin, V. S., van Aalten, D. M. F., Agnew, B. and Kuster, B. (2013) Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J. Proteome Res. 12, 927-936
7. Copeland, R. J., Han, G. and Hart, G. W. (2013) O-GlcNAcomics: revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics. Proteomics Clin. Appl., doi:10.1002/prca.201300001
8. Nandi, A., Sprung, R., Barma, D. K., Zhao, Y., Kim, S. C., Falck, J. R. and Zhao, Y. (2006) Global identification of O-GlcNAc-modified proteins. Anal. Chem. 78, 452-458 (Pubitemid 43100377)
9. Banerjee, S., Robbins, P. W. and Samuelson, J. (2009) Molecular characterization of nucleocytosolic O-GlcNAc transferases of Giardia lambliaand Cryptosporidium parvum. Glycobiology 19, 331-336
10. Kelly, W. G. and Hart, G. W. (1989) Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell 57, 243-251 (Pubitemid 19112364)
11. Hartweck, L. M., Scott, C. L. and Olszewski, N. E. (2002) Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics 161, 1279-1291 (Pubitemid 34831451)
12. Hart, G. W., Haltiwanger, R. S., Holt, G. D. and Kelly, W. G. (1989) Glycosylation in the nucleus and cytoplasm. Annu. Rev. Biochem. 58, 841-874 (Pubitemid 19172989)
13. Olszewski, N. E., West, C. M., Sassi, S. O. and Hartweck, L. M. (2010) O-GlcNAc protein modification in plants: evolution and function. Biochim. Biophys. Acta 1800, 49-56
14. Woosley, B., Xie, M., Wells, L., Orlando, R., Garrison, D., King, D. and Bergmann, C. (2006) Comprehensive glycan analysis of recombinant Aspergillus niger endo-polygalacturonase C. Anal. Biochem. 354, 43-53 (Pubitemid 43816380)
15. Wells, L., Kreppel, L. K., Comer, F. I., Wadzinski, B. E. and Hart, G. W. (2004) O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279, 38466-38470 (Pubitemid 39295998)
16. Dias, W. B., Cheung, W. D., Wang, Z. and Hart, G. W. (2009) Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification. J. Biol. Chem. 284, 21327-21337
17. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934 (Pubitemid 35425239)
18. Roos, M. D. and Hanover, J. A. (2000) Structure of O-linked GlcNAc transferase: mediator of glycan-dependent signaling. Biochem. Biophys. Res. Commun. 271, 275-280 (Pubitemid 30444716)
19. Dong, D. L. and Hart, G. W. (1994) Purification and characterization of an O-GlcNAc selective N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269, 19321-19330
20. Copeland, R. J., Bullen, J. W. and Hart, G. W. (2008) Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295, E17-E28
21. Vocadlo, D. J. (2012) O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation. Curr. Opin. Chem. Biol. 16, 488-497
22. Jínek, M., Rehwinkel, J., Lazarus, B. D., Izaurralde, E., Hanover, J. A. and Conti, E. (2004) The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha. Nat. Struct. Mol. Biol. 11, 1001-1007 (Pubitemid 39315305)
23. Martinez-Fleites, C., He, Y. and Davies, G. J. (2010) Structural analyses of enzymes involved in the O-GlcNAc modification. Biochim. Biophys. Acta 1800, 122-133
24. Zeytuni, N. and Zarivach, R. (2012) Structural and functional discussion of the tetra-trico-peptide repeat, a protein interaction module. Structure 20, 397-405
25. Chen, Q., Chen, Y., Bian, C., Fujiki, R. and Yu, X. (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493, 561-564
26. Vella, P., Scelfo, A., Jammula, S., Chiacchiera, F., Williams, K., Cuomo, A., Roberto, A., Christensen, J., Bonaldi, T., Helin, K. et al. (2013) Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol. Cell 49, 645-656
27. Cheung, W. D., Sakabe, K., Housley, M. P., Dias, W. B. and Hart, G. W. (2008) O-linked β-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J. Biol. Chem. 283, 33935-33941
28. Yang, X., Zhang, F. and Kudlow, J. E. (2002) Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110, 69-80 (Pubitemid 34874607)
29. Shafi, R., Iyer, S. P. N., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W. and Marth, J. D. (2000) The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97, 5735-5739 (Pubitemid 30367467)
30. Jang, H., Kim, T. W., Yoon, S., Choi, S.-Y., Kang, T.-W., Kim, S.-Y., Kwon, Y.-W., Cho, E.-J. and Youn, H.-D. (2012) O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11, 62-74
31. Slawson, C., Zachara, N. E., Vosseller, K., Cheung, W. D., Lane, M. D. and Hart, G. W. (2005) Perturbations in O-linked β-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J. Biol. Chem. 280, 32944-32956 (Pubitemid 41368344)
32. Macauley, M. S. and Vocadlo, D. J. (2010) Increasing O-GlcNAc levels: an overview of small-molecule inhibitors of O-GlcNAcase. Biochim. Biophys. Acta 1800, 107-121
33. Gloster, T. M. and Vocadlo, D. J. (2012) Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nat. Chem. Biol. 8, 683-694
34. Dorfmueller, H. C., Borodkin, V. S., Blair, D. E., Pathak, S., Navratilova, I. and van Aalten, D. M. F. (2011) Substrate and product analogues as human O-GlcNAc transferase inhibitors. Amino Acids 40, 781-792
35. Cecioni, S. and Vocadlo, D. J. (2013) Tools for probing and perturbing O-GlcNAc in cells and in vivo. Curr. Opin. Chem. Biol., doi:10.1016/j.cbpa.2013. 06.030
36. Cantarel, B. L., Coutinho, P. M., Rancurel, C., Bernard, T., Lombard, V. and Henrissat, B. (2009) The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 37, D233-D238
37. Kreppel, L. K., Blomberg, M. A. and Hart, G. W. (1997) Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 272, 9308-9315 (Pubitemid 27154943)
38. Clarke, A. J., Hurtado-Guerrero, R., Pathak, S., Schüttelkopf, A. W., Borodkin, V., Shepherd, S. M., Ibrahim, A. F. M. and van Aalten, D. M. F. (2008) Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J. 27, 2780-2788
39. Martinez-Fleites, C., Macauley, M. S., He, Y., Shen, D. L., Vocadlo, D. J. and Davies, G. J. (2008) Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation. Nat. Struct. Mol. Biol. 15, 764-765 (Pubitemid 351932003)
40. Lazarus, M. B., Nam, Y., Jiang, J., Sliz, P. and Walker, S. (2011) Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469, 564-567
41. Schimpl, M., Zheng, X., Borodkin, V. S., Blair, D. E., Ferenbach, A. T., Schüttelkopf, A. W., Navratilova, I., Aristotelous, T., Albarbarawi, O., Robinson, D. A et al. (2012) O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis. Nat. Chem. Biol. 8, 969-974
42. Konrad, R. J., Zhang, F., Hale, J. E., Knierman, M. D., Becker, G. W. and Kudlow, J. E. (2002) Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun. 293, 207-212 (Pubitemid 34694192)
43. Lenzen, S., Freytag, S. and Panten, U. (1988) Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme. Mol. Pharmacol. 34, 395-400
44. Weaver, D. C., McDaniel, M. L. and Lacy, P. E. (1978) Alloxan uptake by isolated rat islets of Langerhans. Endocrinology 102, 1847-1855 (Pubitemid 8376446)
45. Gorus, F. K., Malaisse, W. J. and Pipeleers, D. G. (1982) Selective uptake of alloxan by pancreatic β-cells. Biochem. J. 208, 513-515 (Pubitemid 13166396)
46. Lenzen, S. (2008) The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 51, 216-226
47. Wu, T., Zhou, H., Jin, Z., Bi, S., Yang, X., Yi, D. and Liu, W. (2009) Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur. J. Pharmacol. 613, 93-99
48. 2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am. J. Physiol. Cell Physiol. 290, C57-C65
49. Yanagisawa, M. and Yu, R. K. (2009) O-linked β-N- acetylglucosaminylation in mouse embryonic neural precursor cells. J. Neurosci. Res. 87, 3535-3545
50. Kaasik, K., Kivimäe, S., Allen, J. J., Chalkley, R. J., Huang, Y., Baer, K., Kissel, H., Burlingame, A. L., Shokat, K. M., Ptáček, L. J. et al. (2013) Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab. 17, 291-302
51. 2/M transition in Xenopus laevis oocytes. J. Biol. Chem. 282, 12527-12536 (Pubitemid 47100627)
52. Tallent, M. K., Varghis, N., Skorobogatko, Y., Hernandez-Cuebas, L., Whelan, K., Vocadlo, D. J. and Vosseller, K. (2009) In vivomodulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. J. Biol. Chem. 284, 174-181
53. Tiedge, M., Richter, T. and Lenzen, S. (2000) Importance of cysteine residues for the stability and catalytic activity of human pancreatic β cell glucokinase. Arch. Biochem. Biophys. 375, 251-260 (Pubitemid 30158381)
54. Lee, T. N., Alborn, W. E., Knierman, M. D. and Konrad, R. J. (2006) Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-β-D-glucosaminidase. Biochem. Biophys. Res. Commun. 350, 1038-1043
55. Lenzen, S. and Munday, R. (1991) Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem. Pharmacol. 42, 1385-1391
56. Cohen, P. (2010) Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 425, 53-54
57. Gross, B. J., Kraybill, B. C. and Walker, S. (2005) Discovery of O-GlcNAc transferase inhibitors. J. Am. Chem. Soc. 127, 14588-14589 (Pubitemid 41510995)
58. Love, D. C. and Hanover, J. A. (2005) The hexosamine signaling pathway: deciphering the 'O-GlcNAc code'. Sci. STKE 2005, re13
59. Hayakawa, K., Hirosawa, M., Tabei, Y., Arai, D., Tanaka, S., Murakami, N., Yagi, S. and Shiota, K. (2013) Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. J. Biol. Chem. 288, 17099-17110
60. Pantaleon, M., Tan, H. Y., Kafer, G. R. and Kaye, P. L. (2010) Toxic effects of hyperglycemia are mediated by the hexosamine signaling pathway and O-linked glycosylation in early mouse embryos. Biol. Reprod. 82, 751-758
61. 473 correlates with apoptosis of murine pancreatic β cells. Exp. Cell Res. 314, 2238-2248 (Pubitemid 351833109)
62. D'Alessandris, C., Andreozzi, F., Federici, M., Cardellini, M., Brunetti, A., Ranalli, M., Del Guerra, S., Lauro, D., Del Prato, S., Marchetti, P. et al. (2004) Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic β-cells. FASEB J. 18, 959-961 (Pubitemid 39561491)
63. Zachara, N. E., O'Donnell, N., Cheung, W. D., Mercer, J. J., Marth, J. D. and Hart, G. W. (2004) Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279, 30133-30142 (Pubitemid 38937936)
64. Han, I., Oh, E. S. and Kudlow, J. E. (2000) Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem. J. 350, 109-114
65. Housley, M. P., Rodgers, J. T., Udeshi, N. D., Kelly, T. J., Shabanowitz, J., Hunt, D. F., Puigserver, P. and Hart, G. W. (2008) O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283, 16283-16292
66. Dion, H. W., Fusari, S. A., Jakubowski, Z. L., Zora, J. G. and Bartz, Q. R. (1956) 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. II. Isolation and characterization. J. Am. Chem. Soc. 78, 3075
67. James, L. R., Tang, D., Ingram, A., Ly, H., Thai, K., Cai, L. and Scholey, J. W. (2002) Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. Diabetes 51, 1146-1156 (Pubitemid 34438362)
68. James, L. R., Ingram, A., Ly, H., Thai, K., Cai, L. and Scholey, J. W. (2001) Angiotensin II activates the GFAT promoter in mesangial cells. Am. J. Physiol. Renal Physiol. 281, F151-F162
69. Hennebicq-Reig, S., Lesuffleur, T., Capon, C., De Bolos, C., Kim, I., Moreau, O., Richet, C., Hemon, B., Recchi, M. A., Maes, E. et al. (1998) Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-α-D- galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem. J. 334, 283-295 (Pubitemid 28421000)
70. Liu, K., Paterson, A. J., Chin, E. and Kudlow, J. E. (2000) Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: linkage of O-linked GlcNAc to β cell death. Proc. Natl. Acad. Sci. U. S. A. 97, 2820-2825 (Pubitemid 30159255)
71. Jiang, J., Lazarus, M. B., Pasquina, L., Sliz, P. and Walker, S. (2012) A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase. Nat. Chem. Biol. 8, 72-77
72. Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T. and Mills, I. G. (2013) O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer. Cancer Res. 73, 5277-5287
73. Filhoulaud, G., Guillemain, G. and Scharfmann, R. (2009) The hexosamine biosynthesis pathway is essential for pancreatic beta cell development. J. Biol. Chem. 284, 24583-24594
74. Gloster, T. M., Zandberg, W. F., Heinonen, J. E., Shen, D. L., Deng, L. and Vocadlo, D. J. (2011) Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat. Chem. Biol. 7, 174-181
75. Olivier-Van Stichelen, S., Drougat, L., Dehennaut, V., El Yazidi-Belkoura, I., Guinez, C., Mir, A.-M., Michalski, J.-C., Vercoutter-Edouart, A.-S. and Lefebvre, T. (2012) Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 1, e36
76. Perez-Cervera, Y., Dehennaut, V., Aquino Gil, M., Guedri, K., Solorzano Mata, C. J., Olivier-Van Stichelen, S., Michalski, J.-C., Foulquier, F. and Lefebvre, T. (2013) Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains. FASEB J. 27, 3478-3486
77. Ma, Z., Vocadlo, D. J. and Vosseller, K. (2013) Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells. J. Biol. Chem. 288, 15121-15130
78. Hart, G. W., Housley M. P. and Slawson, C. (2007) Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022 (Pubitemid 46676063)
79. Macauley, M. S., Whitworth, G. E., Debowski, A. W., Chin, D. and Vocadlo, D. J. (2005) O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280, 25313-25322 (Pubitemid 40962233)
80. Rao, F. V., Dorfmueller, H. C., Villa, F., Allwood, M., Eggleston, I. M. and van Aalten, D. M. F (2006) Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J. 25, 1569-1578
81. Roos, M. D., Xie, W., Su, K., Clark, J. A., Yang, X., Chin, E., Paterson, A. J. and Kudlow, J. E. (1998) Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Physicians 110, 422-432 (Pubitemid 28421930)
82. Konrad, R. J., Janowski, K. M. and Kudlow, J. E. (2000) Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets. Biochem. Biophys. Res. Commun. 267, 26-32 (Pubitemid 30072502)
83. Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., Zheng, X., Kime, R., Read, K. D. and van Aalten, D. M. F. (2010) Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases. Chem. Biol. 17, 1250-1255
84. Pathak, S., Dorfmueller, H. C., Borodkin, V. S. and van Aalten, D. M. F. (2008) Chemical dissection of the link between streptozotocin, O-GlcNAc, and pancreatic cell death. Chem. Biol. 15, 799-807
85. Raikieten, N., Raikieten, M. L. and Nadkarni, M. V. (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91-98
86. Hanover, J. A., Lai, Z., Lee, G., Lubas, W. A. and Sato, S. M. (1999) Elevated O-linked N-acetylglucosamine metabolism in pancreatic β-cells. Arch. Biochem. Biophys. 362, 38-45 (Pubitemid 29391649)
87. Schnedl, W. J., Ferber, S., Johnson, J. H. and Newgard, C. B. (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326-1333
88. Konrad, R. J., Mikolaenko, I., Tolar, J. F., Liu, K. and Kudlow, J. E. (2001) The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic β-cell O-GlcNAc-selective N-acetyl-β-D- glucosaminidase. Biochem. J. 356, 31-41 (Pubitemid 34275703)
89. Toleman, C., Paterson, A. J., Shin, R. and Kudlow, J. E. (2006) Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog. Biochem. Biophys. Res. Commun. 340, 526-534 (Pubitemid 43021780)
90. Gao, Y., Parker, G. J. and Hart, G. W. (2000) Streptozotocin-induced β-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Arch. Biochem. Biophys. 383, 296-302
91. Yamamoto, H., Uchigata, Y. and Okamoto, H. (1981) Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature 294, 284-286 (Pubitemid 12221500)
92. Turk, J., Corbett, J. A., Ramanadham, S., Bohrer, A. and McDaniel, M. L. (1993) Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197, 1458-1464 (Pubitemid 24042786)
93. Beer, D., Maloisel, J.-L., Rast, D. M. and Vasella, A. (1990) Synthesis of 2-acetamido-2-deoxy-D-gluconhydroximolactone-and chitobionhydroximolactone- derived N-phenylcarbamates, potential inhibitors of N-acetylglucosaminidase? Helv. Chim. Acta 73, 1918-1922 (Pubitemid 20353197)
94. Haltiwanger, R. S., Grove, K. and Philipsberg, G. A. (1998) Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivousing the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate. J. Biol. Chem. 273, 3611-3617 (Pubitemid 28109786)
95. Macauley, M. S., Bubb, A. K., Martinez-Fleites, C., Davies, G. J. and Vocadlo, D. J. (2008) Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J. Biol. Chem. 283, 34687-34695
96. Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., Shepherd, S. M., Shpiro, N. A. and van Aalten, D. M. F. (2006) GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-GlcNAcylation levels. J. Am. Chem. Soc. 128, 16484-16485 (Pubitemid 46032711)
97. Mehdy, A., Morelle, W., Rosnoblet, C., Legrand, D., Lefebvre, T., Duvet, S. and Foulquier, F. (2012) PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells. J. Biochem. 151, 439-446
98. Shanmugasundaram, B., Debowski, A. W., Dennis, R. J., Davies, G. J., Vocadlo, D. J. and Vasella, A. (2006) Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor. Chem. Commun. 10, 4372-4374 (Pubitemid 44611693)
99. Pédelacq, J.-D., Cabantous, S., Tran, T., Terwilliger, T. C. and Waldo, G. S. (2006) Engineering and characterization of a superfolder green fluorescent protein. Nat. Biotechnol. 24, 79-88 (Pubitemid 43083170)
100. Knapp, S., Vocadlo, D. J., Gao, Z., Kirk, B., Lou, J. and Withers, S. G. (1996) NAG-thiazoline, an N-acetyl-β-hexosaminidase inhibitor that implicates acetamido participation. J. Am. Chem. Soc. 118, 6804-6805 (Pubitemid 26248188)
101. Vosseller, K., Wells, L., Lane, M. D. and Hart, G. W. (2002) Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 5313-8 (Pubitemid 34411545)
102. Champattanachai, V., Marchase, R. B. and Chatham, J. C. (2008) Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am. J. Physiol. Cell Physiol. 294, C1509-C1520
103. Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P., Sethi, G., Walker, S., Vosseller, K. and Reginato, M. J. (2010) Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29, 2831-2842
104. Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J. et al. (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4, 483-490
105. Yu, Y., Zhang, L., Li, X., Run, X., Liang, Z., Li, Y., Liu, Y., Lee, M. H., Grundke-Iqbal, I., Iqbal, K. et al. (2012) Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation. PLoS ONE 7, e35277
106. Goldberg, H., Whiteside, C. and Fantus, I. G. (2011) O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am. J. Physiol. Endocrinol. Metab. 301, E713-E726
107. Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q. and Yu, W. (2011) O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim. Biophys. Acta 1812, 514-519
108. Dorfmueller, H. C., Borodkin, V. S., Schimpl, M. and van Aalten, D. M. F. (2009) GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation. Biochem. J. 420, 221-227
109. Pathak, S., Borodkin, V. S., Albarbarawi, O., Campbell, D. G., Ibrahim, A. and van Aalten, D. M. (2012) O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release. EMBO J. 31, 1394-1404
110. Borodkin, V. S. and van Aalten, D. M. F. (2010) An efficient and versatile synthesis of GlcNAcstatins-potent and selective O-GlcNAcase inhibitors built on the tetrahydroimidazo[1, 2-a]pyridine scaffold. Tetrahedron 66, 7838-7849
111. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105
112. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
113. Bain, J., McLauchlan, H., Elliott, M. and Cohen, P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204 (Pubitemid 36458094)
114. Majumdar, G., Wright, J., Markowitz, P., Martinez-Hernandez, A., Raghow, R. and Solomon, S. S. (2004) Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1. Diabetes 53, 3184-3192 (Pubitemid 39564494)
115. Dennis, R. J., Taylor, E. J., Macauley, M. S., Stubbs, K. A., Turkenburg, J. P., Hart, S. J., Black, G. N., Vocadlo, D. J. and Davies, G. J. (2006) Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity. Nat. Struct. Mol. Biol. 13, 365-371 (Pubitemid 43873509)
116. Li, T., Guo, L., Zhang, Y., Wang, J., Li, Z., Lin, L., Zhang, Z., Li, L., Lin, J., Zhao, W. et al. (2011) Design and synthesis of O-GlcNAcase inhibitors via 'click chemistry' and biological evaluations. Carbohydr. Res. 346, 1083-1092